Document Type : Original Article
Authors
1 Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 Professor, Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 Associate Professor, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4 Associate Professor, Department of Neurology, Firoozgar Hospital, Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences (IUMS), Tehran, Iran
Abstract
Background:Echogenic liposomes (ELIPs) encapsulate drugs and gas bubbles within lipid vesicles. The destruction of ELIPs in response to MHz and kHz ultrasound waves has been studied previously. Applying ultrasound above a certain threshold causes encapsulated gas bubbles destruct rapidly by fragmentation or more slowly by acoustically driven diffusion. This study compares the destruction of recombinant tissue plasminogen activator (rtPA) -loaded echogenic liposomes using three frequency protocols: 130 kHz, 1 MHz and dual (130 kHz + 1 MHz).
Method:In gel phantom, ELIPs were imaged by diagnostic ultrasound system and simultaneously destructive ultrasonic fields were applied at different intensities in each protocol. Images were analyzed.
Results:According to the results, 80% decline in MGV (mean of gray value) relative to initial MGV was associated with ELIPs fragmentation. At 130 kHz, results showed an 80% decline in MGV and fragmentation happened at all applied ultrasound intensities (0.01 W/cm2 as fragmentation threshold). In MHz and dual protocols, on average, less than 50% decline in MGV was observed which indicated an acoustically driven diffusion.
Conclusion:Our study shows that kHz protocol fragments ELIPs more effectively than other two protocols. For better results, dual frequency protocols need optimized combination of frequencies and phases.
Keywords
- Frinking PJ, Cespedes EI, Kirkhorn J, Torp HG, de Jong N. A new ultrasound contrast imaging approach based on the combination of multiple imaging pulses and a separate release burst. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48(3):643–51.
- Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97(5):473-83.
- Unger EC, McCreery TP, Sweitzer RH, Caldwell VE, Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 1998; 33(12):886–92.
- Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48(1):232–48.
- Raymond JL, Luan Y, Peng T, Huang SL, McPherson DD, Versluis M, et al. Loss of gas from echogenic liposomes exposed to pulsed ultrasound. Phys Med Biol 2016; 61(23):8321-39.
- Chen WS, Matula TJ, Brayman AA, Crum LA. A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents. J Acoust Soc Am 2003; 113(1):643–51.
- Bouakaz A, Versluis M, de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol 2005; 31(3):391–99.
- Postema M, Bouakaz A, Versluis M, de Jong N. Ultrasound-induced gas release from contrast agent microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52(6):1035–41.
- Porter TM, Smith DAB, Holland CK. Acoustic techniques for assessing the Optison destruction threshold. J Ultrasound Med 2006; 25(12):1519–29.
- Smith DA, Porter TM, Martinez J, Huang S, MacDonald RC, McPherson DD, et al. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol 2007; 33(5):797–809.
- Radhakrishnan K, Bader KB, Haworth KJ, Kopechek JA, Raymond JL, Huang SL, et al. Relationship between cavitation and loss of echogenicity from ultrasound contrast agents. Phys Med Biol 2013; 58(18): 6541–63.
- Neppiras EA. Acoustic cavitation. Phys Rep 1980; 61(3):159–251.
- Apfel RE, Holland CK. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 1991; 17(2):179–85.
- Saletes I, Gilles B, Bera JC. Promoting inertial cavitation by nonlinear frequency mixing in a bifrequency focused ultrasound beam. Ultrasonics 2011; 51(1):94–101.
- Sokka SD, Gauthier TP, Hynynen K. Theoretical and experimental validation of a dual-frequency excitation method for spatial control of cavitation. Phys Med Biol 2005; 50(9):2167–79.
- Hasanzadeh H, Mokhtari-Dizaji M, Bathaie SZ, Hassan ZM, Nilchiani V, Goudarzi H. Enhancement and control of acoustic cavitation yield by low-level dual frequency sonication: a subharmonic analysis. Ultrason Sonochem 2011; 18(1):394–400.
- Barati AH, Mokhtari-Dizaji M, Mozdarani H, Bathaie Z, Hassan ZM. Effect of exposure parameters on cavitation induced by low-level dual-frequency ultrasound. Ultrason Sonochem 2007; 14(6):783-9.
- Ebrahiminia A, Mokhtari-Dizaji M, Toliyat T. Dual frequency cavitation event sensor with iodide dosimeter. Ultrason Sonochem 2016; 28:276-82.
- Ebrahiminia A, Mokhtari-Dizaji M, Toliyat T. Correlation between iodide dosimetry and terephthalic acid dosimetry to evaluate the reactive radical production due to the acoustic cavitation activity. Ultrason Sonochem 2013; 20(1):366-72.
- Roth JM. Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke. Proc (Bayl Univ Med Cent) 2011; 24(3):257-59.
- Smith DA, Vaidya SS, Kopechek JA, Huang SL, Klegerman ME, McPherson DD, Holland CK. Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol 2010; 36(1):145–57.
- Shaw GJ, Meunier JM, Huang SL, Lindsell CJ, McPherson DD, Holland CK. Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes. Thromb Res 2009; 124(3):306–10.
- Bader KB, Bouchoux G, Peng T, Klegerman ME, McPherson DD, Holland CK. Thrombolytic efficacy and enzymatic activity of rt-PA-loaded echogenic liposomes. J Thromb Thrombolysis 2015; 40(2):144–55.
- Shekhar H, Bader KB, Huang S, Peng T, Huang S, McPherson DD, et al. In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas. Phys Med Biol 2017; 62(2):517-38.
- Tiukinhoy-Laing SD, Huang S, Klegerman M, Holland CK, McPherson DD. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 2007; 119(6):777–84.
- Laing ST, Moody MR, Kim H, Smulevitz B, Huang SL, Holland CK, et al. Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model. Thromb Res 2012; 130(4):629-35.
- Hua X, Zhou L, Liu P, He Y, Tan K, Chen Q, et al. In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model. J Thromb Thrombolysis 2014; 38(1):57-64.
- Jaffe GJ, Green GDJ, Abrams GW. Stability of Recombinant Tissue Plasminogen Activator. Am J Ophthalmol 1989; 108(1):90–1.
- Shaw GJ, Sperling M, Meunier JM. Long-term stability of recombinant tissue plasminogen activator at -80 C. BMC Res Notes 2009; 2:117.
- Huang SL, McPherson DD, MacDonald RC. A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery. Ultrasound Med Biol 2008; 34(8):1272–80.
- Mokhtari-Dizaji M. Tissue-mimicking materials for teaching sonographers and evaluation of their specifications after three years. Ultrasound Med Biol 2001; 27(12):1713-16.
- Paul S, Russakow D, Nahire R, Nandy T, Ambre AH, Katti K, et al. In vitro measurement of attenuation and nonlinear scattering from echogenic liposomes. Ultrasonics 2012; 52(7):962-9.
)